Condition: Urologic Diseases · Prostate Biopsy · Flexible Cystoscopy · Sponsor: Istituto Oncologico Veneto IRCCS
Though the efficacy of VRH is documented in various outpatient urological procedures and has provided promising preliminary information in prostate biopsy, its systematic use in urology remains poorly studied. Considering the potential of invasive urological procedures to induce significant patient discomfort, the application of innovative immersive approaches, such as those offered by medical devices, could lead to an overall clinical benefit. Among these, REALICA® (available from https://REALICA.io/en/), a class I CE medical device, widely used in hospitals and validated by numerous studies, represents a valuable resource in urology, supported by high satisfaction rates received in abdominal surgery and extracorporeal lithotripsy
This description comes directly from the study's public registry record.
Antonio Amodeo, MD · 0423-421321 · antonio.amodeo@iov.veneto.it
Gian Luca De Salvo, MD · 0498215704 · clinical.trial@iov.veneto.it
Always discuss trial participation with your own doctor first.
| Istituto Oncologico Veneto IRCCS | Padova, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07338292